Novel mutations of AXIN2 identified in a Chinese Congenital Heart Disease Cohort
Novel mutations of AXIN2 identified in a Chinese Congenital Heart Disease Cohort
复制标题
在中国先天性心脏病队列中发现的 AXIN2 新突变
DOI:
10.1038/s10038-019-0572-x
复制
发表时间:
2019
影响因子:
3.5
通讯作者:
Chen Fengshan
中科院分区:
文献类型:
--
作者:
Zhu Mengjiao;Ma Xiaoyun;Ding Peicheng;Tang Hanfei;Peng Rui;Lu Lei;Li Peiqiang;Qiao Bin;Yang Xueyan;Zheng Yufang;Wang Hongyan;Gao Yunqian;Chen Fengshan
Congenital heart defects (CHDs), the most common congenital human birth anomalies, involves complex genetic factors. Wnt/β-catenin pathway is critical for cardiogenesis and proved to be associated with numerous congenital heart abnormities. AXIN2 has a unique role in Wnt/β-catenin pathway, as it is not only an important inhibitor but also a direct target of Wnt/β-catenin pathway. However, whether AXIN2 is associated with human CHDs has not been reported. In our present study, we found a differential expression ofAxin2mRNA during the development of mouse heart, indicating its importance in mouse cardiac development. Then using targeted next-generation sequencing, we found two novel case-specific rare mutations [c.28 C > T (p.L10F), c.395 A > G (p.K132R)] in the sequencing region ofAXIN2. In vitro functional analysis suggested that L10F might be a loss-of-function mutation and K132R is a gain-of-function mutation. Both mutations disrupted Wnt/β-catenin pathway and failed to rescue CHD phenotype caused byAxin2knockdown in zebrafish model. Collectively, our study indicates that rare mutations inAXIN2might contribute to the risk of human CHDs and a balanced canonical Wnt pathway is critical for cardiac development process. To our knowledge, it is the first study ofAXIN2mutations associated with human CHDs, providing new insights into CHD etiology.